Discover 212 paid clinical trials in Montana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you’re looking to join as a healthy volunteer in a paid clinical trial or need condition-specific options, Montana has a wide range of research opportunities to suit. Active recruitment is underway at research centers in Billings, Missoula, and Great Falls, allowing participants to access advanced treatments and high-quality medical care.
Filter
1
Filter results
Results: 212
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Molecular Basis of Human Phagocyte Interactions With Bacterial Pathogens
for
Host Defense Mechanisms
Location: Hamilton MT
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT00339287
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
for
Non-Small Cell Lung Cancer
Location: Burlington MA, Hartford CT, New Haven CT, Lebanon NH,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT05899608
Phase3, Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Boston MA, Westbury NY, New York NY, Washington D.C. DC,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase1, Phase2, Recruiting
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
for
Asthma
Location: The Bronx NY, Miami FL, Charleston SC, Cleveland OH,
Sponsor: GlaxoSmithKline
Sex: All
Age: 12 - 17
Code: NCT05757102
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Montreal, Winston-Salem NC, Pittsburgh PA, Charlotte NC,
Sponsor: Incyte Corporation
Sex: Female
Age: 18+
Code: NCT07214779
Phase3, Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: The Bronx NY, Albany NY, East Brunswick NJ,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase2, Recruiting
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Boston MA, Lebanon NH, Stony Brook NY, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Providence RI, Worcester MA, New York NY, Sewell NJ,
Sponsor: NRG Oncology
Sex: Female
Age: 18+
Code: NCT06388018
Phase2, Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection
for
Clostridium Difficile (C. Difficile)
Location: Saint Johns, San Antonio TX, Butte MT, Idaho Falls ID,
Sponsor: Deinove
Sex: All
Age: 18+
Code: NCT03988855
Phase2, Recruiting
The PRIME Study: A Randomized, Controlled, Prospective Study
for
Patient Preference, Patient Outcomes,
Location: Bozeman MT
Sponsor: Vance Thompson Vision - MT
Sex: All
Age: 22 - 70+
Code: NCT04549935
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Augusta ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06498635
Phase3, Recruiting
Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata
for
Alopecia Areata, Scarring Alopecia
Location: North Attleboro MA, Stevensville MT, Irvine CA
Sponsor: Regeneris Medical
Sex: All
Age: 18 - 70+
Code: NCT03078686
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)